CRIS Competitors & Alternatives
Compare Curis Inc with similar stocks in the same industry
Biotechnology
CRIS
Main Stock$0.39
Tradestie Score
54
Market Cap
$20.87M
P/E Ratio
0.3
Revenue Growth
-0.7%
Analyst Upside
+10945.0%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.75
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.49
|
$158.43M | - | 58 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 48 | Compare |
|
AGEN
Agenus Inc.
|
$6.33
|
$124.27M | 2.5 | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 49 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 58 | Compare |
More CRIS Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry